Thus, this study’s aim was the evaluation of activated STAT3 and the influence of JAK1/2-inhibitor baricitinib (BA) on inflammatory processes such as the complement system in PXE. This evidence concerns the gene JAK1 and pseudoxanthoma elasticum (inherited or acquired).